Anzeige
Mehr »
Login
Samstag, 25.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
387 Leser
Artikel bewerten:
(1)

Kiteworks Protects Employee and Contractor PHI; Enables Compliance With HIPAA and Vaccine Mandates

Finanznachrichten News

PALO ALTO, Calif., Jan. 19, 2022, the leading platform for ensuring regulatory compliance and effectively managing risk with every send, share, receive, and save of sensitive content, announced today that customers can use Kiteworks for uploading, sharing, and storing vaccine-related protected health information (PHI) for employees, contractors, visitors, students, and educators. In doing so, Kiteworks enables organizations to protect sensitive PHI and comply with the Health Insurance Portability and Accountability Act (HIPAA) and other privacy regulations.

"Kiteworks provides an automated, comprehensive PHI content-sharing process that makes it easy for employees, contractors, students, educators, and others to upload vaccine mandate-related content," said Bob Ertl, Senior Director of Enterprise Solutions at Kiteworks. "It also provides a detailed audit trail that organizations can use to demonstrate compliance with both vaccine mandates and HIPAA."

Vaccine Mandates in the Public and Private Sectors
The earliest U.S. federal mandates, announced by the White Housein July 2021, required vaccination or weekly testing for civilian employees of the federal government and on-site federal contractors. In August 2021, Defense Secretary Lloyd Austin announcedthat coronavirus shots would be added to the Pentagon's required immunization list upon full approval of a vaccine by the Food and Drug Administration (FDA).

While some broader federal mandates have seen recent setbacks, many vaccine requirements in the U.S. are being voluntarily initiated within individual businesses. More than halfhave, or plan to issue, vaccine mandates for employees. Many New York City-based companies, including Goldman Sachs, Morgan Stanley, and Citigroup, already require vaccines for anyone coming into the office. In some locations, participation may be required by state or local regulations. For example, government employees in 19 statesare currently required to be vaccinated.

Ensuring Effective Governance, Risk Management, and Compliance
Organizations must be able to demonstrate that they have the right controls in place by implementing content access and functional rules matched to risk profiles and user roles. Without such controls, there is a risk of accidental exposure of employee records to peers due to missing access controls, or unencrypted attachments sent through email due to a lack of encryption policies.

Organizations also need to track PHI by logging every action. Detailed tracking ensures comprehensive visibility, which becomes particularly important for auditing and reporting processes to demonstrate compliance.

Kiteworks Simplifies Vaccine Mandate Management
As vaccine mandates have just begun rolling out, many organizations have not had sufficient time to plan and execute a data management program that anticipates the complexities of governance and compliance risks.

Key capabilities of the Kiteworks platform include:

  • Unify. Kiteworks provides a centralized system that standardizes multiple content audit trails and unifies secure content communication channels. Employees, contractors, and others can transmit required COVID-19 vaccine and/or testing documentation via mobile devices, web interfaces, or even email attachments.

  • Track. Kiteworks tracks the activity of each COVID-19 vaccination and testing record by logging every action-downloads, uploads, views, sends, and permission changes.

  • Control. Kiteworks lets organizations set policies according to role rather than manually configuring each user, which reduces administrative time and ultimately reduces the risk of human error, while making compliance documentation easier.

  • Secure. Kiteworks uses a layered defense model to protect sensitive content regardless of the source, and whether it is at rest or in motion. Data is automatically encrypted with every send, upload, download, and save.

Additional Resources
Webinar: How To Protect PHI and Comply With HIPAA While Meeting Employee Vaccine Mandates

Guide: A Guide on Employee Vaccine Mandates While Complying With HIPAA

Blog Post: Employee Vaccination Mandates Accentuate the Need for HIPAA-compliant File Transfer for HR Professionals

About Kiteworks
Kiteworks' mission is to empower organizations to effectively manage risk in every send, share, receive, and save of sensitive content. To this end, we created a platform that delivers content governance, compliance, and protection to customers. The platform unifies, tracks, controls, and secures sensitive content moving within, into, and out of their organization, significantly improving risk management and ensuring regulatory compliance on all sensitive content communications.

Media Contacts
Danielle Ostrovsky
Hi-Touch PR


© 2022 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.